PBM over­haul and drug price ne­go­ti­a­tions make the cut in Re­pub­li­can­s' tax bill

The lat­est ver­sion of a mas­sive and wide-rang­ing tax cut bill in­cludes sev­er­al pro-phar­ma re­forms re­lat­ed to phar­ma­cy ben­e­fit man­agers and the way the drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA